bd onclarity hpv assay is the only health canada-licensed test that supports self-collection with hpv extended genotyping to measure a woman’s risk for cervical pre-cancer and cancer more precisely, so high-risk women can receive earlier intervention.
when you consider the numbers of people impacted by hpv, the self-collection screening kit is a critical step forward. more than 70 per cent of sexually active canadians of all ages will have hpv at some point. the compounding problem is, the high-risk strains of the virus that can cause cancer are asymptomatic, so people don’t know they have it – unless they’ve been screened for hpv. the highest prevalence is found in people 20 to 24 years of age.
experts in hpv and cervical cancer point out that there is still confusion about hpv among the public and many healthcare providers. hpv isn’t just about cervical cancer; it can also lead to penile cancer, anal cancer in both women and men, and oropharyngeal cancer of the throat including the base of the tongue and tonsils.
further, high-risk strains of hpv don’t present symptoms, but low-risk strains also don’t show obvious signs of infection. genital warts, for example, are one symptom, but these can be small or be hidden inside the body, out of sight. and while for women, the warts may be spotted on the vulva, thigh, anus, rectum or inside the vagina or urethra, men can find the warts on the penis, scrotum, thigh, anus, rectum or in the urethra.